End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
645.6 INR | -2.34% | -3.58% | -10.67% |
Mar. 27 | Suven Pharmaceuticals Limited Announces Shifting of Registered Office | CI |
Mar. 05 | Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call |
Sales 2023 | 13.4B 161M | Sales 2024 * | 10.9B 131M | Capitalization | 164B 1.96B |
---|---|---|---|---|---|
Net income 2023 | 4.11B 49.26M | Net income 2024 * | 3.34B 40.02M | EV / Sales 2023 | 8.97 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 15 x |
P/E ratio 2023 |
29.2
x | P/E ratio 2024 * |
49
x | Employees | 1,193 |
Yield 2023 * |
0.36% | Yield 2024 * |
0.27% | Free-Float | 37.48% |
Latest transcript on Suven Pharmaceuticals Limited
1 day | -2.34% | ||
1 week | -3.58% | ||
Current month | -2.24% | ||
1 month | +2.32% | ||
3 months | +3.30% | ||
6 months | +16.00% | ||
Current year | -10.67% |
Managers | Title | Age | Since |
---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 23-09-28 |
Himanshu Agarwal
DFI | Director of Finance/CFO | 30 | Dec. 31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 23-09-28 | |
Shweta Jalan
BRD | Director/Board Member | 48 | Nov. 08 |
Director/Board Member | 62 | Nov. 08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.01% | 0 M€ | +3.95% | - | |
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 643.9 | -0.27% | 43,550 |
24-05-09 | 645.6 | -2.34% | 67,938 |
24-05-08 | 661.1 | -0.74% | 122,213 |
24-05-07 | 666 | -0.36% | 155,647 |
24-05-06 | 668.4 | -0.55% | 61,022 |
End-of-day quote NSE India S.E., May 08, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.67% | 1.96B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- SUVENPHAR Stock